KawasakiTKosakiFOkawaSShigematsuIYanagawaH. A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan. Pediatrics. 1974;54:271-276.
4.
NewburgerJWTakahashiMGerberMA. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-2771.
5.
PoonLKLunKSNgYM. Facial nerve palsy and Kawasaki disease. Hong Kong Med J. 2000;6:224-226.
6.
KingWJSchlieperABirdiNCappelliMKornelukYRowePCThe effect of Kawasaki disease in cognition and behavior. Arch Pediatr Adolesc Med. 2000;154:463-468.
7.
OhnoSMiyajimaTHiguchiM. Ocular manifestations of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Ophthalmol. 1982;93:713-717.
8.
KnottPDOrloffLAHarrisJPNovakREBurnsJC. Sensorineural hearing loss associated and Kawasaki disease: a prospective study. Am J Otolaryngol. 2001;22:343-348.
9.
SmithKAYunkerWK. Kawasaki disease is associated with sensorineural hearing loss: a systematic review. Int J Pediatr Otorhinolaryngol. 2014;78:1216-1220.
10.
ThapaRChakrabarttyS. Atypical Kawasaki disease with remarkable paucity of signs and symptoms. Rheumatol Int. 2009;29:1095-1096.
